Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655549 · ClinicalTrials.gov registry record · Phase 1
A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects
A Phase 1 study, sponsored by Pfenex.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT02655549 is a Phase 1 study that has completed, run by Pfenex. The registered enrollment target is 54 participants.
The verdict
NCT02655549, a Phase 1 study, has completed, sponsored by Pfenex.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The trial investigates Px563L and RPA563, two formulations of a novel anthrax vaccine.
Interventions
- BIOLOGICAL Px563L, RPA563, or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02655549
The ClinicalTrials.gov registry entry for NCT02655549 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfenex, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Px563L, RPA563, or placebo is the first listed.
NCT02655549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02655549 about?
NCT02655549 is a clinical study titled "A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects". The trial investigates Px563L and RPA563, two formulations of a novel anthrax vaccine.
What is the current status of trial NCT02655549?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2015-12. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02655549?
The interventions under investigation include: Px563L, RPA563, or placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT02655549?
This trial is sponsored by Pfenex, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.